Page 5 - Genomic Sequencing News Today

According to Prophecy Market Insights "Bioinformatics Platform Market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to register

/PRNewswire/ -- What is a Bioinformatics Platform? Bioinformatics is the effective use of biological data and application of computer technology. Large volumes...

Researchers discuss major healthcare-associated pathogens, as well as current and future public health priorities related to these microorganisms.

In this inspiring interview, we speak to Dr. Radoje Drmanac, co-founder of Complete Genomics, about the past, present, and future of genomics research.

With the increase in the number of samples for genome sequencing, Dr Karyakarte said, Pune-CoG -- a consortium of five Indian SARS-CoV2 Genomics Consortium (INSACOG) labs in the city -- will be activated. Apart from NIV and BJMC, the other three labs include National Centre for Cell Science, National Chemical Laboratory, and Indian Institute of Science Education and Research.

Looking to learn more from genomics sequencing about DNA mutations and cancer, researchers applied a long-read approach to get a broader genomic view.

20.03.2023 - Genome Sequencing and Interpretation Services Progressing Quickly for 1,000 Newborns Enrolled in Study to Date; On Track to Support up to 100,000 Study Participants in Next Four YearsInitial Data and Analysis Presented at the ACMG (American College ... Seite 1

NEW DELHI, Feb 26 : Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, DrJitendra Singh today said, Government will promote Industry driven StartUps . Addressing the 37th Foundation day of Department of Biotechnology (DBT), as chief guest, at National Institute of Immunology (NII) here, DrJitendra Singh called for equal stakes with equal partnership...

A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient's disease returning by looking at DNA mutations in their tumors.

Researchers have linked tumor DNA mutations to kidney cancer recurrence, suggesting that treatment and follow-up can be optimized based on genetic factors.